Location: New York, NY
CIK: 0001826434 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $813M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ASND | ASCENDIS PHARMA A/S | 258,740 | $69.01M | 8.5% | — | — | ORD SHS | K08588103 |
| ELVN | ENLIVEN THERAPEUTICS INC | 866,716 | $43.99M | 5.4% | — | — | COM | 29337E102 |
| RVMD | REVOLUTION MEDICINES INC | 151,822 | $28.43M | 3.5% | — | — | COM | 76155X100 |
| CYTK | CYTOKINETICS INC | 194,000 | $16.53M | 2.0% | — | — | COM NEW | 23282W605 |
| BBNX | BETA BIONICS INC | 493,344 | $7.731M | 1.0% | — | — | COM | 08659B102 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AXSM | AXSOME THERAPEUTICS INC. | 219,308 (+253.1%) | $53.68M (+411.3%) | 6.6% | — | — | COM | 05464T104 |
| VRTX | VERTEX PHARMACEUTICALS INC | 201,791 (+56.0%) | $100M (+73.6%) | 12.3% | — | — | COM | 92532F100 |
| LLY | ELI LILLY & CO | 76,532 (+23.8%) | $91.79M (+61.5%) | 11.3% | — | — | COM | 532457108 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 221,720 (+39.7%) | $53.43M (+78.1%) | 6.6% | — | — | SHS USD | G50871105 |
| ARGX | ARGENX SE | 41,596 (+31.5%) | $38.59M (+67.1%) | 4.7% | — | — | SPONSORED ADR | 04016X101 |
| DXCM | DEXCOM INC | 820,479 (+17.5%) | $55.26M (+26.0%) | 6.8% | — | — | COM | 252131107 |
| JNJ | JOHNSON & JOHNSON | 424,945 (+2.5%) | $108M (+6.5%) | 13.3% | — | — | COM | 478160104 |
| TARS | TARSUS PHARMACEUTICALS INC | 328,340 (+30.0%) | $20.67M (+16.6%) | 2.5% | — | — | COM | 87650L103 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 132,413 | $65.08M | 8.0% | — | — | — | 883556102 |
| ASND | ASCENDIS PHARMA A/S | 255,332 | $58.4M | 7.2% | — | — | — | 04351P101 |
| NUVL | NUVALENT INC | 308,506 | $31.61M | 3.9% | — | — | — | 670703107 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 47,983 (-68.7%) | $19.08M (-73.0%) | 2.3% | — | — | COM NEW | 46120E602 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 68,273 (-33.9%) | $36.66M (-32.2%) | 4.5% | — | — | COM | 558868105 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 47,026 (-33.2%) | $25.48M (-38.9%) | 3.1% | — | — | COM | 91307C102 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 746,835 (-26.9%) | $25.3M (-17.7%) | 3.1% | — | — | SPONSORED ADS | 881624209 |
| DFTX | DEFINIUM THERAPEUTICS INC | 162,996 (-55.9%) | $7.667M (+9.8%) | 0.9% | — | — | COM SHS | 24477V105 |
| DNTH | DIANTHUS THERAPEUTICS INC | 120,712 (-17.1%) | $11.77M (-3.7%) | 1.4% | — | — | COM | 252828108 |